Bellerophon Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
04 Mar 2024	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
30 Jan 2024	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
22 Jan 2024	8-K: Submission of Matters to a Vote of Security Holders; Other Events
10 Jan 2024	8-K: Submission of Matters to a Vote of Security Holders; Other Events
12 Dec 2023	8-K: Submission of Matters to a Vote of Security Holders; Other Events
21 Nov 2023	8-K: Departure/Election of Directors or Officers; Compensation
13 Oct 2023	8-K: Departure/Election of Directors or Officers; Compensation
13 Oct 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
07 Aug 2023	8-K: Departure/Election of Directors or Officers; Compensation
24 Jul 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
20 Jul 2023	8-K: Departure/Election of Directors or Officers; Compensation
14 Jul 2023	8-K: Departure/Election of Directors or Officers; Compensation
29 Jun 2023	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more
09 Jun 2023	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
05 Jun 2023	8-K: Other Events
15 May 2023	8-K: Results of Operations and Financial Condition
11 May 2023	8-K: Departure/Election of Directors or Officers; Compensation
11 May 2023	8-K: Other Events
05 May 2023	8-K: Departure/Election of Directors or Officers; Compensation
25 Apr 2023	8-K: Departure/Election of Directors or Officers; Compensation

Comments